Craig A. Bunnell

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Johanna C. Bendell, Susan M. Domchek, Harold J. Burstein et al. · Cancer · 2003 · 1.3K citations

Medicine, Neurology, Oncology +17

Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer

Harold J. Burstein, Irene Kuter, Susana M. Campos et al. · Journal of Clinical Oncology · 2001 · 369 citations

Medicine, Oncology, Pharmacology +17

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Harold J. Burstein, Lyndsay N. Harris, P. Kelly Marcom et al. · Journal of Clinical Oncology · 2003 · 345 citations

Medicine, Oncology, Pharmacology +17

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

Eva Thomas, Josep Tabernero, Monica Fornier et al. · Journal of Clinical Oncology · 2007 · 290 citations · Full text

Medicine, Oncology, Pharmacology +15

Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer: A Pilot Study

Harold J. Burstein, Lyndsay N. Harris, Rebecca Gelman et al. · Journal of Clinical Oncology · 2002 · 277 citations

Medicine, Oncology, Pharmacology +17